Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:administeredBy |
cats
|
| gptkbp:CASNumber |
1416992-39-6
|
| gptkbp:chemicalClass |
peptidomimetic compound
|
| gptkbp:developedBy |
gptkb:feline_infectious_peritonitis
|
| gptkbp:hasMolecularFormula |
C21H32N4O7S
|
| https://www.w3.org/2000/01/rdf-schema#label |
GC376
|
| gptkbp:investigatedBy |
gptkb:COVID-19
|
| gptkbp:mechanismOfAction |
3CL protease inhibitor
|
| gptkbp:molecularWeight |
500.57 g/mol
|
| gptkbp:relatedTo |
GC373
|
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:status |
investigational drug
|
| gptkbp:studiedBy |
veterinary researchers
|
| gptkbp:target |
coronavirus main protease
|
| gptkbp:usedIn |
gptkb:veterinary_medicine
|
| gptkbp:bfsParent |
gptkb:SARS-CoV-2_main_protease
gptkb:NSP5 |
| gptkbp:bfsLayer |
7
|